EQUIP FT SUSPENSION INJECTABLE POUR CHEVAUX ET PONEYS
EQUIP FT SUSPENSION INJECTABLE POUR CHEVAUX ET PONEYS
Authorised
- Equine influenza virus H3N8, A/equine/Borlange/2/91, Inactivated
- Equine influenza virus H7N7, A/equine/Newmarket/1/77, Inactivated
- Clostridium tetani, toxoid
- Equine influenza virus H3N8, A/equine/Kentucky/2/98, Inactivated
Product identification
Medicine name:
EQUIP FT SUSPENSION INJECTABLE POUR CHEVAUX ET PONEYS
Active substance:
- Equine influenza virus H3N8, A/equine/Borlange/2/91, Inactivated
- Equine influenza virus H7N7, A/equine/Newmarket/1/77, Inactivated
- Clostridium tetani, toxoid
- Equine influenza virus H3N8, A/equine/Kentucky/2/98, Inactivated
Target species:
-
Equid
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Equine influenza virus H3N8, A/equine/Borlange/2/91, Inactivated2.20log10 haemagglutination inhibiting unit(s)2.00millilitre(s)
-
Equine influenza virus H7N7, A/equine/Newmarket/1/77, Inactivated1.20log10 haemagglutination inhibiting unit(s)2.00millilitre(s)
-
Clostridium tetani, toxoid70.00international unit(s)2.00millilitre(s)
-
Equine influenza virus H3N8, A/equine/Kentucky/2/98, Inactivated2.74log10 haemagglutination inhibiting unit(s)2.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Equid
-
All relevant tissues0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI05AL01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- National Veterinary Medicines Agency
Authorisation number:
- FR/V/8448928 9/1995
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/11/2023
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/11/2023
How useful was this page?: